[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368023-105":59,"doc-detail-368023-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","development-and-validation-of-a-machine-learning-driven-mitochondrial-gene-signature-for-the-diagnosis-of-breast-cancer","Development and validation of a machine learning-driven mitochondrial gene signature for the diagnosis of breast cancer","","Breast cancer is a highly prevalent malignancy, and mitochondrial dysfunction is implicated in its pathogenic mechanisms. This study explores links between mitochondrial function-related genes and breast cancer progression by identifying differentially expressed genes, building co-expression network modules, and training a machine learning diagnostic model using mitochondrial genetics data. Functional enrichment clarifies mitochondrial biological processes, while tissue-based high-throughput validation, immune infiltration, and single-cell analyses support key gene roles. Computational drug prediction, docking, and molecular dynamics further evaluate candidate therapeutics, yielding a model with strong C-index performance and 18 potential biomarkers.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-a-machine-learning-driven-mitochondrial-gene-signature-for-the-diagnosis-of-breast-cancer/368023/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-a-machine-learning-driven-mitochondrial-gene-signature-for-the-diagnosis-of-breast-cancer/368023.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main goal regarding breast cancer?","Question",{"text":112,"@type":113},"To investigate how mitochondrial function-related genes relate to breast cancer progression and to develop a machine learning diagnostic model for distinguishing tumor from normal tissue.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were candidate diagnostic biomarkers and the model built?",{"text":117,"@type":113},"Differentially expressed genes were identified from the GEO database, key modules were defined using a weighted co-expression network, and a mitochondrial gene-based diagnostic model was constructed using machine learning algorithms and mitochondrial genetics data.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supported the biological relevance of the mitochondrial genes?",{"text":121,"@type":113},"High-throughput tissue chip experiments and immunohistochemistry validated key gene expression in tissues, while immune infiltration and single-cell analyses highlighted roles of NK cells and T cells in the tumor microenvironment.",{"name":123,"@type":110,"acceptedAnswer":124},"How were potential therapeutic candidates evaluated?",{"text":125,"@type":113},"Computational drug prediction and molecular docking were used to propose candidates, and molecular dynamics simulations assessed binding interactions, with Eugenol showing strong binding to AIFM2 and ACADS.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},368023,1790218693,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Original Research PUBLISHED 03 December 2025 DOI 10.3389/fimmu.2025.1712089  \nOPEN ACCESS  \nEDITED BY  \nKrishnendu Bera,  \nItalian National Research Council-Istituto Ofﬁcina dei Materiali (IOM) c/o International School for Advanced Studies (SISSA), Italy  \nREVIEWED BY  \nPetr Simecek,  \nCentral European Institute of Technology (CEITEC), Czechia  \nKuntal Kumar Dey,  \nUniversity of California, Davis, United States  \n*CORRESPONDENCE  \nMeng Liu  \n [15210511316@126.com](15210511316@126.com)[ ](15210511316@126.com)Jian Ren  \n [renjian@sdutcm.edu.cn](renjian@sdutcm.edu.cn)  \n† These authors have contributed equally to this work  \nRECEIVED 24 September 2025  \nREVISED 15 November 2025  \nACCEPTED 17 November 2025  \nPUBLISHED 03 December 2025  \nCITATION  \nTong S, Teng F, Kong W, Tian X, Guo D, Liu Mand Ren J (2025) Development and validation of a machine learning-driven mitochondrial gene signature for the diagnosis of breast cancer.  \nFront. Immunol. 16:1712089 .  \ndoi: 10.3389/fimmu.2025.1712089  \nCOPYRIGHT  \n© 2025 Tong, Teng, Kong, Tian, Guo, Liu and Ren. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nDevelopment and validation of a machine learning-driven mitochondrial gene signature for the diagnosis of breast cancer  \nSiyu Tong1†, Fei Teng 2†, Weijia Kong 3,4†, Xuanhe Tian 5, Dong Guo 6, Meng Liu 7* and Jian Ren 1*  \n1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China, 2 Beijing University of Chinese Medicine Third Afﬁliated Hospital, Beijing, China,  \n3Guang ’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, 4Graduate School, Beijing University of Chinese Medicine, Beijing, China, 5 First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China, 6Shandong University of Traditional Chinese Medicine, Jinan, China, 7Oncology Department of Integrated Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China  \nBackground: Breast cancer (BC) ranks among the most prevalent malignant tumors in women globally, with mitochondrial dysfunction constituting one of its pathogenic mechanisms.  \nObjectives: To investigate the relationship between mitochondrial functionrelated genes and BC progression.  \nMethods: We identiﬁed BC differentially expressed genes via the GEO database, constructed a weighted co-expression network to determine BC pathogenesisrelated key modules. Using 113 machine learning algorithms and MitoCarta mitochondrial genetics data, we developed a mitochondrial gene-based diagnostic model. GO/KEGG enrichment analyses delineated BC-related biological processes of mitochondrial genes, offering clues for understanding BC mechanism. High-throughput tissue chip and Immunohistochemistry (IHC) validated key genes’ local expression in tissues. CiberSort immune inﬁltration analysis highlighted NK and T cells’ role in BC; single-cell analysis identiﬁed gene expression patterns across tumor microenvironment cell types. Computational drug prediction and molecular docking explored targeted therapeutic candidates. Additionally, we conducted molecular dynamics simulations. Results: The glmBoost+LDA model had the highest C-index (0 . 947) in the validated cohort, including 18 potential BC biomarkers (e.g., ACADS, AUC = 0. 810; AIFM2, AUC = 0 . 806) . The results of experimental validation showed that the expression score of ACADS in cancerous tissues was signiﬁcantly lower than that in adjacent non-cancerous tissues. Immune inﬁltration and single-cell analyses emphasized the crucial roles of N","cbCaijbY7CEDH10F","https://ap.wps.com/l/cbCaijbY7CEDH10F","pdf",18898316,22,"English","# Background and objectives\n# Methods\n# Results\n## Diagnostic performance and biomarkers\n## Experimental validation and immune analyses\n## Therapeutic prediction and molecular dynamics\n# Conclusions","[{\"question\":\"What is the study’s main goal regarding breast cancer?\",\"answer\":\"To investigate how mitochondrial function-related genes relate to breast cancer progression and to develop a machine learning diagnostic model for distinguishing tumor from normal tissue.\"},{\"question\":\"How were candidate diagnostic biomarkers and the model built?\",\"answer\":\"Differentially expressed genes were identified from the GEO database, key modules were defined using a weighted co-expression network, and a mitochondrial gene-based diagnostic model was constructed using machine learning algorithms and mitochondrial genetics data.\"},{\"question\":\"What evidence supported the biological relevance of the mitochondrial genes?\",\"answer\":\"High-throughput tissue chip experiments and immunohistochemistry validated key gene expression in tissues, while immune infiltration and single-cell analyses highlighted roles of NK cells and T cells in the tumor microenvironment.\"},{\"question\":\"How were potential therapeutic candidates evaluated?\",\"answer\":\"Computational drug prediction and molecular docking were used to propose candidates, and molecular dynamics simulations assessed binding interactions, with Eugenol showing strong binding to AIFM2 and ACADS.\"}]","Development and validation of a machine learning-driven mitochondrial gene signature for the diagnosis of breast cancer | PDF",1790174421,55,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01f9f27432cd8818ae9e2379ea4fbc68.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0133a86f758ccee857a061553118c9af.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1a42381efaa3038ea16a422ec5c3a7e.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e194daf9d12a762bdf158d33430b9d5a.webp",980,1385]